Results 51 to 60 of about 9,406 (131)

An immunofluorescence microscopy assay to discriminate distinct expression patterns of HIV-1 Gag and Nef proteins in HIV-1 provirus-harboring cells. [PDF]

PLoS One
Wiscovitch-Russo R, Sui H, Smith M, Imamichi H, Lane HC, Imamichi T.   +5 more
europepmc   +1 more source

Biomimetic bone scaffold functionalized with traditional Chinese medicine ingredients and collagen-binding IGF-1 for bone regeneration. [PDF]

J Mater Sci Mater Med
Gao X, Lei B, Zhao X, Zhang Y.
europepmc   +1 more source

HIV-1 Nef Uses a Conserved Pocket to Recruit the N-Terminal Cytoplasmic Tail of Serinc3. [PDF]

Viruses
Karimian Shamsabadi M, Stoneham C, De Leon A, Fares T, Guatelli J, Jia X.   +5 more
europepmc   +1 more source

Dual Functionality of miRNAs During HIV Infection: From Viral Genome Suppression to Immune Response Modulation. [PDF]

Epigenomes
Timofeeva AM, Aulova KS, Nevinsky GA.
europepmc   +1 more source

Turning defense into damage: HIV-driven amyloidogenesis and neurotoxicity. [PDF]

mBio
Gu F, Saed B, Naghavi MH.
europepmc   +1 more source

Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-κB, and AP-1 induction. Vol. 279 (2004) 39520–39531

Journal of Biological Chemistry, 2005
Jean-François Fortin, Corinne Barat, Yannick Beauséjour, Benoit Barbeau, Michel J. Tremblay   +4 more
openaire   +1 more source

Ancestral reconstruction supports that loss of Nef-mediated T cell modulation coincided with the emergence of pathogenic lentiviruses. [PDF]

J Virol
Baldino AM, Mumby MJ, Edgar CR, Olabode AS, Poon AFY, Dikeakos JD.   +5 more
europepmc   +1 more source

HIV and Cancer: Insights into Viral-Mediated Oncogenesis and Immunosuppression. [PDF]

Pathogens
Lasagna A, Pozza G, Matone M, Fasola C, Ruggieri L, La Verde N, Pedrazzoli P, Dalu D.   +7 more
europepmc   +1 more source

Nef stabilizes actin to prevent HIV-1 sensing by RIG-I-like receptors. [PDF]

Nat Commun
Laliberté A, Prelli Bozzo C, Acharya D, De Luna A, Hirschenberger M, Zhu J, Volcic M, Stolp B, Rodriguez-Quinteros CM, Fackler OT, Gack MU, Sparrer KMJ, Kirchhoff F.   +12 more
europepmc   +1 more source

Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound. [PDF]

J Clin Invest
Omange WR, Varco-Merth BD, Fadeyi O, Marenco A, Takata H, Duell DM, Goodwin WD, Armitage P, Fennessey CM, Kose E, Immonen TT, Kosmider E, Bosche WJ, Fast R, Homick C, Oswald K, Shoemaker R, Bochart R, MacAllister R, Labriola CS, Smedley JV, Axthelm MK, Edlefsen PT, Keele BF, Lifson JD, Gergen J, Petsch B, Rauch S, Picker LJ, Okoye AA.   +29 more
europepmc   +1 more source